Valuation: DataMEDS AI, Inc.

Market Cap 6.74M 6.03M 5.57M 5.04M 9.42M 641M 9.57M 66.41M 26.49M 336M 25.28M 24.74M 1.06B P/E 2024 *
-
P/E 2025 -0.28x
Enterprise Value 31.28M 28.02M 25.85M 23.39M 43.74M 2.98B 44.44M 308M 123M 1.56B 117M 115M 4.94B EV / Sales 2024 *
-
EV / Sales 2025 2,769,122x
Free-Float
55.37%
Yield 2024 *
-
Yield 2025 -
1 day-6.83%
1 week-10.88%
Current month-35.34%
1 month-44.15%
3 months-31.67%
6 months-61.97%
Current year-89.74%
1 week 1.97
Extreme 1.97
2.37
1 month 1.97
Extreme 1.97
4.35
Current year 0.82
Extreme 0.8225
22.5
1 year 0.82
Extreme 0.8225
40.85
3 years 0.82
Extreme 0.8225
352
5 years 0.82
Extreme 0.8225
352
10 years 0.82
Extreme 0.8225
352
Manager TitleAgeSince
Chief Executive Officer 44 2026-05-19
Chief Executive Officer 52 2025-10-02
Director of Finance/CFO 40 2025-10-06
Director TitleAgeSince
Chairman 55 2022-09-05
Director/Board Member 80 2025-10-01
Director/Board Member 52 2025-10-01
Date Insider Type Main position Quantity % Market Cap. Importance
6/22/26 Option

Chief Executive Officer

200,000 7.9573%
3/31/26 Free

Founder

10,000,000 11.1446%
3/31/26 Free

Chief Executive Officer

10,000,000 11.1446%
Change 5-day change 1-year change 3-year change Capi.($)
-8.64%-10.88%-93.43% - 6.74M
+0.12%+4.51%+26.64%+62.88% 260B
+0.55%+2.73%+10.29%+27.52% 165B
+0.71%+0.98%-16.63%+73.39% 154B
-1.28%-8.45%-58.01%-15.84% 61.49B
+2.60%+5.09%+14.50%+51.83% 52.9B
+0.70%+2.71%-13.09%-6.29% 52.84B
-1.83%-3.26%+8.84%+63.98% 51.46B
-0.52%+4.10%+26.41%+78.93% 51.16B
+0.11%+5.51%+39.95%+103.08% 46.85B
Average -0.53%-0.71%-5.45%+48.83% 89.57B
Weighted average by Cap. +0.28%+1.41%+6.99%+51.13%

Financials

2024 2025
Net sales 18.13 16.24 14.98 13.56 25.35 1.73K 25.76 178.72 71.3 903.5 68.04 66.59 2.86K 23.34 20.9 19.29 17.45 32.63 2.22K 33.16 230.08 91.79 1.16K 87.58 85.72 3.68K
Net income -6.86M -6.14M -5.67M -5.13M -9.59M -653M -9.74M -67.59M -26.97M -342M -25.73M -25.18M -1.08B -101M -90.71M -83.69M -75.73M -142M -9.64B -144M -998M -398M -5.05B -380M -372M -15.99B
Net Debt 23.97M 21.47M 19.81M 17.92M 33.52M 2.28B 34.06M 236M 94.28M 1.19B 89.96M 88.04M 3.78B 24.54M 21.98M 20.28M 18.35M 34.32M 2.34B 34.87M 242M 96.52M 1.22B 92.1M 90.14M 3.87B
Projected Income Statement - Annual - DataMEDS AI, Inc.
Logo DataMEDS AI, Inc.
DataMeds AI, Inc., formerly Wellgistics Health, Inc., is a holding company. It is engaged in health information technology (IT) that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units. The Company conducts its business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC, and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows clinical services to be connected to its health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, prescription price transparency, and provide additional concierge services.
Employees
-
Date Price Change Volume
26-10-29 US$2.010 -8.64% 161,588
26-10-28 US$2.200 +6.80% 347,469
26-10-27 US$2.060 -5.94% 360,323
26-10-26 US$2.190 -1.79% 617,523
26-10-23 US$2.230 -3.04% 376,469
  1. Stock Market
  2. Stocks
  3. MEDS Stock